# Comparison of 1.5T vs. 3T Protocols After Treatment With Glatiramer Acetate (GA)

> **NCT00937157** · NA · COMPLETED · sponsor: **University at Buffalo** · enrollment: 12 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DRUG:** Copaxone

## Key facts

- **NCT ID:** NCT00937157
- **Lead sponsor:** University at Buffalo
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09
- **Primary completion:** 2010-07
- **Final completion:** 2011-04
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2021-03-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00937157

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00937157, "Comparison of 1.5T vs. 3T Protocols After Treatment With Glatiramer Acetate (GA)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00937157. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*